Pfizer has launched Rimegepant ODT in India for adults who don’t respond to triptans. The fast-acting tablet offers up to ...
Pfizer introduces Rimegepant ODT in India for migraine treatment, offering rapid, sustained relief without overuse headache ...
This prompted an unusual and bitter bidding war, where Doustdar goaded Pfizer to raise its bid during a press conference in the Oval Office. In the end, Pfizer won by matching Novo’s $10bn offer, as ...
Traditionally, developing a new drug can take over a decade, but AI technology is changing that timeline. Major pharmaceutical companies like Pfizer and AstraZeneca are leveraging AI to accelerate the ...
This article is authored by Dr Jitendra Kumar, managing director, Biotechnology Industry Research Assistance Council (BIRAC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback